NEPH
Nephros IncNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$37.67M
P/E Ratio
49.57
EPS
$0.07
Beta
1.47
52W High
$6.42
52W Low
$2.28
50-Day MA
$3.10
200-Day MA
$4.22
Dividend Yield
—
Profit Margin
4.06%
Forward P/E
—
PEG Ratio
0.00
About Nephros Inc
Nephros, Inc., a commercial stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company is headquartered in South Orange, New Jersey.
Fundamentals
| Revenue (TTM) | $19.12M |
| Gross Profit (TTM) | $11.46M |
| EBITDA | 803,000 |
| Operating Margin | 1.86% |
| Return on Equity | 7.76% |
| Return on Assets | 3.31% |
| Revenue/Share (TTM) | $1.80 |
| Book Value | $0.99 |
| Price-to-Book | 3.61 |
| Price-to-Sales (TTM) | 1.97 |
| EV/Revenue | 1.861 |
| EV/EBITDA | 41.01 |
| Quarterly Earnings Growth (YoY) | -80.00% |
| Quarterly Revenue Growth (YoY) | 6.90% |
| Shares Outstanding | $10.86M |
| Float | $8.83M |
| % Insiders | 12.84% |
| % Institutions | 49.48% |
Historical Volatility
HV 10-Day
166.02%
HV 20-Day
126.98%
HV 30-Day
109.33%
HV 60-Day
93.26%
HV Rank
68.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($7.00 target)
2
Strong BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026